Get Your Personalized Supplement StackSupplement Stack Quiz

goBHB

Also known as: BHB, Beta-hydroxybutyrate ketone, exogenous ketones, Beta-hydroxybutyrate

Overview

Beta-hydroxybutyrate (BHB) is a ketone body naturally produced in the liver during periods of fasting, carbohydrate restriction, or prolonged exercise, serving as an alternative energy source to glucose for the brain and muscles. Exogenous BHB supplements directly provide this ketone body to the bloodstream, rapidly raising blood ketone levels. Its primary uses include inducing or augmenting ketosis for metabolic benefits, improving glycemic control, enhancing cognitive function, and supporting overall energy metabolism. BHB can lower blood glucose without increasing insulin, and it is available in various forms, including salt and ester formulations. Research on BHB is moderately advanced, with multiple systematic reviews and meta-analyses supporting its metabolic effects, particularly its ability to increase blood BHB concentrations and reduce blood glucose. While short-term safety and efficacy are well-supported, long-term data are still emerging.

Benefits

BHB supplementation reliably increases blood BHB concentrations in a dose-dependent manner, as confirmed by meta-regression analyses, indicating a strong correlation between the administered dose and achieved blood levels. A significant benefit is its ability to reduce blood glucose levels without increasing insulin secretion, particularly noted in populations with obesity or prediabetes, which points to improved glycemic control. This effect is clinically relevant, with meta-analyses reporting statistically significant glucose reductions. Secondary effects include increased cerebral blood flow and reduced cerebral glucose oxidation when administered intravenously, suggesting potential neuroprotective effects. Acute studies in healthy individuals have also shown a modest increase in metabolic rate and a reduction in state anxiety. The benefits are particularly pronounced for obese and prediabetic individuals due to the glucose-lowering effects without an added insulin load. Blood BHB levels rise rapidly after supplementation, with sustained effects depending on the dose and formulation.

How it works

BHB functions as an alternative energy substrate by entering the mitochondria of cells, where it is converted to acetyl-CoA, which then fuels the Krebs cycle for energy production. This process allows the body to utilize fat for fuel, especially when glucose is scarce. BHB modulates glucose metabolism by reducing the body's reliance on glucose and decreasing insulin secretion. It also influences cerebral metabolism by increasing cerebral blood flow and altering glucose utilization in the brain. At a molecular level, BHB can act on G-protein coupled receptors, such as HCAR2, and has been shown to inhibit histone deacetylases, which can influence gene expression and inflammatory pathways. When consumed orally, BHB is rapidly absorbed, with blood levels dependent on the dose and specific formulation (salts vs. esters), with esters generally yielding higher BHB concentrations.

Side effects

BHB is generally considered safe for short-term use in both healthy individuals and clinical populations, with intravenous administration also appearing safe in limited studies. Common side effects, though not extensively detailed in the provided sources, can include mild gastrointestinal discomfort, which is a known issue with oral ketone supplements. No significant adverse effects have been reported in the cited studies for uncommon (1-5%) or rare (<1%) occurrences. There are no major drug interactions reported, but caution is advised when combining BHB with glucose-lowering medications due to potential additive effects on blood glucose. Contraindications are not well-defined, but caution is recommended for individuals at risk of ketoacidosis or those with severe metabolic disorders. Long-term safety data are limited, especially for specific populations such as children, pregnant women, or individuals with severe renal impairment.

Dosage

The minimum effective dose to achieve significant blood BHB concentrations (e.g., >2 mmol/L) is approximately 0.2 g/kg/h when administered intravenously. For oral supplementation, optimal dosage ranges vary, but meta-analyses indicate that different doses produce dose-dependent increases in blood BHB levels. A clearly established maximum safe dose for oral BHB is not available, though intravenous dosing is limited by tolerability and cost. Acute effects are observed within hours of administration, and sustained dosing protocols vary depending on the study and desired outcome. Ketone salts and ketone esters are the primary forms; esters generally produce higher BHB levels but may have a less palatable taste and higher cost compared to salts. Oral bioavailability is influenced by the specific formulation and whether it is consumed with food. No specific cofactors are required, but maintaining proper hydration and electrolyte balance is important, especially with ketone salts.

FAQs

Is Gobhb safe for daily use?

Short-term use of BHB appears safe based on current research. However, long-term safety data, especially regarding chronic daily use, are still limited and require further investigation.

Does it cause hypoglycemia?

BHB modestly lowers blood glucose without increasing insulin, so the risk of hypoglycemia is low. However, individuals with diabetes on glucose-lowering medications should exercise caution and monitor blood sugar.

When to take for best effect?

The optimal timing depends on your goals. Taking BHB before exercise or during fasting states may maximize ketone utilization and energy benefits. Acute effects are observed within hours.

Will it suppress appetite?

Current evidence does not strongly support significant appetite suppression from BHB supplementation. Some studies have shown no significant effect on appetite or energy intake.

Is it better as salt or ester?

Ketone esters generally achieve higher blood ketone levels than ketone salts. However, esters can be more expensive and have a less pleasant taste, while salts are more common and often better tolerated.

Research Sources

https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2023.1202186/full – This systematic review and meta-regression by Storoschuk et al. (2023) analyzed multiple studies to establish a strong dose-response relationship between BHB infusion and blood BHB levels. It provides valuable insights for clinical dosing strategies, although it primarily focused on infusion studies and noted heterogeneity in study designs.
https://pubmed.ncbi.nlm.nih.gov/37327753/ – Yu et al. (2023) conducted a systematic review and meta-analysis of 30 studies, involving 408 participants, demonstrating that exogenous ketones significantly increase blood BHB and lower glucose levels without raising insulin, particularly in individuals with obesity or prediabetes. The study was PROSPERO registered, indicating high quality, despite varied supplement forms and moderate sample sizes across included studies.
https://www.gavinpublishers.com/article/view/beta-hydroxybutyrate-ketone-salt-supplement--alters-energy-metabolism-blood-glucose-and--ketone-levels-but-not-appetite-or-energy-intake – This randomized controlled trial (KS Supplement Study, 2023) involving 22 healthy females found that BHB salt supplementation increased blood ketones and lowered glucose acutely. Importantly, it did not show a significant effect on appetite or energy intake, suggesting that BHB's metabolic benefits may not directly translate to appetite suppression. The study's small sample size and female-only population are limitations.
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.740374/full – White et al. (2021) performed a systematic review focusing on intravenous BHB administration, concluding that it increases cerebral blood flow and alters renal function, with short-term safety. The review highlighted consistent findings across small studies (11-22 participants per study) but noted the limited long-term data, indicating a need for larger and longer-duration trials.
https://pubmed.ncbi.nlm.nih.gov/35380602/ – Falkenhain et al. (2022) conducted a systematic review and meta-analysis confirming the glucose-lowering effects of exogenous ketones. This high-quality, peer-reviewed meta-analysis supports the potential of BHB for glycemic control in metabolic diseases, despite some heterogeneity and small trial sizes among the included RCTs.